The notices it replaced
- Reissues: PAR-24-297 Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- Reissues: PAS-21-270 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
- Reissues: PAS-25-236 D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
- 2 steps back: PA-18-916 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
- 2 steps back: PAR-21-310 Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
- 2 steps back: PAS-24-242 D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
- 3 steps back: PA-18-072 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
- 3 steps back: PAR-18-918 Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- 4 steps back: PA-15-290 AIDS-Science Track Award for Research Transition (R03)
- 4 steps back: PAR-18-081 Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- 5 steps back: PA-12-282 AIDS-Science Track Award for Research Transition (R03)
- 5 steps back: PAR-15-326 Imaging - Science Track Award for Research Transition (I/START) (R03)
- 6 steps back: PAR-10-021 AIDS-Science Track Award for Research Transition (R03)
- 6 steps back: PAR-12-066 Imaging - Science Track Award for Research Transition (I/START) [R03]
- 7 steps back: PA-07-349 AIDS-Science Track Award for Research Transition (R03)
- 7 steps back: PAR-09-073 Imaging - Science Track Award for Research Transition (I/START) [R03]
- 8 steps back: PAR-06-311
- 9 steps back: PAR-06-092
Who won it before
74 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,910,872 in first-year total cost, median $165,188.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-L (51)]12
- HIV Comorbidities and Clinical Studies Study Section[HCCS]7
- Special Emphasis Panel[ZRG1 AARR-K (82)]6
- Special Emphasis Panel[ZRG1 AARR-N (91)]5
- Emerging Imaging Technologies in Neuroscience Study Section[EITN]4
Most frequent institutions
- FLORIDA INTERNATIONAL UNIVERSITY5
- YALE UNIVERSITY5
- MASSACHUSETTS GENERAL HOSPITAL4
- DREXEL UNIVERSITY2
- DUKE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Immune profiling of antibodies and B cells that recognize HIV and substances in people who use substances and live with HIV (PWUSH)1R03DA064474-01 · under PAS-21-270 | WU, XUELING | BOSTON MEDICAL CENTER, MA | $356,630 | HIVD |
| 2025 | Feasibility, Acceptability, and Validity of Remote Sweat-derived Biomarker Collection1R03DA064467-01 · under PAS-21-270 | METHENY, NICHOLAS | EMORY UNIVERSITY, GA | $335,356 | HCCS |
| 2025 | A chemical AI and data science platform for the identification and discovery of novel psychoactive substances1R03DA063752-01 · under PAS-24-242 | SKINNIDER, MICHAEL ALEXANDER | PRINCETON UNIVERSITY, NJ | $164,000 | ZRG1 |
| 2024 | Neural mechanisms underlying opioid consumption1R03DA060335-01A1 · under PAR-21-310 | KAMENS, HELEN M | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $237,600 | NMB |
| 2024 | Development of novel radioligand for PET imaging targeting the orexin 1 receptor1R03DA059714-01 · under PAR-21-310 | KOVACIC, ISABELLE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $193,923 | IPCA |
| 2024 | Neuroimmune and Cognitive Consequences of Nicotine Use in a Rodent Model of HIV: Implications for Anti-Retroviral Therapies1R03DA061626-01A1 · under PAS-21-270 | GIPSON-REICHARDT, CASSANDRA D | UNIVERSITY OF KENTUCKY, KY | $166,375 | HCCS |
| 2024 | Impact of cannabidiol on HIV infection and methamphetamine abuse associated neuroinflammation1R03DA060076-01 · under PAS-21-270 | CHAND, SUBHASH | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $153,500 | HCCS |
| 2024 | HIV effects on astrocytic regulation of stress-induced cocaine reinstatement1R03DA060771-01A1 · under PAS-21-270 | GIACOMETTI, LAURA L | DREXEL UNIVERSITY, PA | $151,500 | HCCS |
| 2023 | Neuroimaging in Pregnancy to Assess Effects of Opioid Use Disorder1R03DA056797-01A1 · under PAR-21-310 | RADHAKRISHNAN, RUPA | INDIANA UNIVERSITY INDIANAPOLIS, IN | $237,750 | EITN |
| 2023 | L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)1R03DA055970-01A1 · under PAR-21-310 | ANDRES, MARILOU A. | UNIVERSITY OF HAWAII AT MANOA, HI | $218,250 | MCNP |
| 2022 | Multimodal magnetoencephalography and electroencephalography exploration of the acute effects of THC exposure on neural noise and information transmission within working memory networks1R03DA054453-01A1 · under PAR-18-918 | CORTES-BRIONES, JOSE A | YALE UNIVERSITY, CT | $196,350 | NPAS |
| 2022 | Social networks and STIs as an indicator of potential HIV transmission and acquisition among PWID1R03DA057142-01 · under PAS-21-270 | SKAATHUN, BRITT | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $158,000 | HIBI |
| 2022 | Investigate B cell perturbations and immune reconstitution failure in response to antiretroviral therapy in HIV-infected cocaine users1R03DA057164-01 · under PAS-21-270 | JIANG, WEI | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $151,000 | HCCS |
| 2022 | Restoring mucociliary clearance apparatus to mitigate lung inflammation in the context of HIV and cigarette smoke1R03DA057162-01 · under PAS-21-270 | CHINNAPAIYAN, SRINIVASAN | FLORIDA INTERNATIONAL UNIVERSITY, FL | $147,500 | HCCS |
| 2022 | Neurocognitive implications of cannabidiol (CBD) while aging with HIV1R03DA057146-01 · under PAS-21-270 | RODRIGUEZ, MYOSOTYS | FLORIDA INTERNATIONAL UNIVERSITY, FL | $147,500 | HCCS |
| 2021 | A new PET neuroimaging probe for sigma 1 receptor1R03DA054126-01 · under PAR-18-918 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $250,640 | EITN |
| 2021 | Imaging presynaptic correlates of cocaine locomotor sensitization with near infrared catecholamine nanosensors1R03DA052810-01 · under PAR-18-918 | LANDRY, MARKITA | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $222,600 | SMI |
| 2021 | A genetically encoded MRI reporter for noninvasive imaging of activity-dependent gene expression in neurons1R03DA050971-01A1 · under PAR-18-918 | MUKHERJEE, ARNAB | UNIVERSITY OF CALIFORNIA SANTA BARBARA, CA | $218,167 | EITN |
| 2021 | Substance use, intersectional stigma, and health outcomes for women living with HIV1R03DA052180-01A1 · under PA-18-916 | TURAN, BULENT | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $148,500 | PPAH |
| 2020 | Selective PET imaging probes targeting BD1 of N-terminal bromodomains1R03DA050860-01A1 · under PAR-18-918 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $249,280 | IPCA |
| 2020 | Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions1R03DA052179-01 · under PA-18-916 | ALI, SYEDVERMUND, STEN H. | YALE UNIVERSITY, CT | $80,871 | PPAH |
| 2019 | Imaging the Opioid Response to Cannabis Smoking1R03DA047588-01 · under PAR-18-081 | HILLMER, ANSEL | YALE UNIVERSITY, CT | $251,250 | ZRG1 |
| 2019 | Developing new PET imaging probes for orexin 1 receptors1R03DA048123-01A1 · under PAR-18-918 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $241,800 | EITN |
| 2019 | Establishing the effect of flavor on the addictive potential of electronic cigarettes1R03DA047582-01A1 · under PAR-18-081 | HOBKIRK, ANDREA | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $229,950 | ZRG1 |
| 2019 | Aberrant Reward Sensitivity: Mechanisms Underlying Substance Use1R03DA046733-01A1 · under PAR-18-081 | SMITH, DAVID VICTOR | TEMPLE UNIV OF THE COMMONWEALTH, PA | $228,736 | ZRG1 |
| 2019 | Alterations in corticostriatal control of cocaine seeking in HIV infection1R03DA047919-01A1 · under PA-18-072 | BARKER, JACQUELINE M | DREXEL UNIVERSITY, PA | $167,000 | ZRG1 |
| 2019 | The impact of abused drug and HIV Tat protein on CRISPR/Cas9 gene editing of HIV provirus in astrocyte reservoir1R03DA048704-01 · under PA-18-072 | HUANG, ZAOHUA | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $153,500 | ZRG1 |
| 2019 | Dose Reduction in Pediatric/Adolescent Brain PET Imaging Through Artificial Neural Networks1R03EB028070-01 · under PAR-18-081 | TANG, JING | OAKLAND UNIVERSITY, MI | $127,590 | ZRG1 |
| 2019 | Modeling combination biomedical substance use interventions to inform a Getting to Zero implementation for Black men who have sex with men1R03DA049662-01 · under PA-18-916 | KHANNA, ADITYA SUBHASH | UNIVERSITY OF CHICAGO, IL | $81,000 | ZRG1 |
| 2018 | Non-invasive neuroimaging of sirtuin 1 using PET1R03EB025959-01A1 · under PAR-15-326 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $251,702 | ZRG1 |
| 2018 | Addiction and Parenting: The role of aberrant reward process1R03DA045289-01A1 · under PAR-15-326 | RUTHERFORD, HELENA JV | YALE UNIVERSITY, CT | $251,250 | ZRG1 |
| 2018 | Peer processes in the social neuroscience of adolescent cannabis use1R03DA045327-01A1 · under PAR-15-326 | CAOUETTE, JUSTIN DANIEL | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $231,000 | ZRG1 |
| 2018 | Longitudinal impacts of neighborhood factors on HIV care continuum outcomes among Black PWID in Baltimore, MD1R03DA044868-01A1 · under PA-15-290 | LINTON, SABRIYA L | JOHNS HOPKINS UNIVERSITY, MD | $163,750 | BSCH |
| 2018 | Lung comorbidities in HIV patients1R03DA042681-01A1 · under PA-15-290 | UNWALLA, HOSHANG JEHANGIR | FLORIDA INTERNATIONAL UNIVERSITY, FL | $146,500 | ZRG1 |
| 2017 | Consequences of nicotine exposure on dopamine D2 binding in Adolescence and adulthood. An in-vivo positron emission tomography (PET) study in rats.1R03DA039989-01A1 · under PAR-15-326 | LEVINE, AMIR | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $264,642 | ZRG1 |
| 2017 | Role of Peripheral & Brain Iron in the Development of Attention & Cognitive Control1R03EB023359-01A1 · under PAR-15-326 | PRITCHARD, ALISON | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $240,798 | ZRG1 |
| 2017 | Neurobehavioral substrates of propranolol's effects on drug cue reactivity1R03DA043756-01A1 · under PAR-15-326 | OLIVER, JASON ANTHONY | DUKE UNIVERSITY, NC | $238,500 | ZRG1 |
| 2017 | Multimodal imaging of neuronal and glial contributions to sleep homeostasis in vivo1R03DA042480-01A1 · under PAR-15-326 | HAYWORTH, CHRISTOPHER ROY | WASHINGTON STATE UNIVERSITY, WA | $229,500 | ZRG1 |
| 2017 | Impact of Early Life Stress on Brain Integrity Among Adolescents with Cannabis Use Disorder1R03DA042183-01A1 · under PAR-15-326 | WAMSER, RACHEL ANN | UNIVERSITY OF MISSOURI-ST. LOUIS, MO | $227,659 | ZRG1 |
| 2017 | Developing a PrEP Screening Instrument for Identification/Referral of High-Risk MSM in Primary Care1R03DA043402-01 · under PA-15-290 | STORHOLM, ERIK D. | RAND CORPORATION, CA | $171,422 | BSPH |
| 2017 | Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors1R03DA041892-01A1 · under PA-15-290 | GELPI-ACOSTA, CAMILA | NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC., NY | $159,932 | ZRG1 |
| 2017 | Preventing HIV/STI in Urban Adolescents via an mHealth Primary Care Intervention1R03DA041891-01A1 · under PA-15-290 | CORDOVA, DAVID | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $155,000 | BSPH |
| 2017 | Functional identification of new mechanisms of neurotoxicity induced by HIV and drugs of abuse1R03DA043428-01A1 · under PA-15-290 | SHTUTMAN, MICHAEL | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $146,500 | ZRG1 |
| 2017 | Intranasal Nanodelivery of Oxytocin to Treat Morphine Addiction in HIV Patients by Gene Editing1R03DA044877-01 · under PA-15-290 | JAYANT, RAHUL DEV | FLORIDA INTERNATIONAL UNIVERSITY, FL | $146,500 | ZRG1 |
| 2017 | An integrated substance use, violence, and HIV/AIDS syndemic risk-reduction intervention for African American Couples1R03DA044866-01 · under PA-15-290 | MITTAL, MONA | UNIV OF MARYLAND, COLLEGE PARK, MD | $146,309 | ZRG1 |
| 2017 | Prescription opiate, drug cue processing network, and neural connectivity1R03DA044496-01 · under PAR-15-326 | RAY, SUCHISMITA | RUTGERS, THE STATE UNIV OF N.J., NJ | $131,921 | ZRG1 |
| 2016 | Measurement of persisting changes in emotional brain functioning produced by psilocybin1R03DA042336-01 · under PAR-15-326 | BARRETT, FREDERICK STREETER | JOHNS HOPKINS UNIVERSITY, MD | $259,832 | ZRG1 |
| 2016 | Neural mechanisms of context-dependent stimulus generalization in humans1R03DA040668-01A1 · under PAR-15-326 | KAHNT, THORSTEN | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $227,123 | ZRG1 |
| 2016 | Motives for Heavy Cannabis Use among Young Men who have Sex with Men Living with HIV/AIDS1R03DA041908-01 · under PA-12-282 | BRUCE, DOUGLAS | DE PAUL UNIVERSITY, IL | $168,845 | ZRG1 |
| 2016 | Activity Space Neighborhoods, Drug Use and HIV among Black MSM in the Jackson, MS MSA1R03DA039748-01A1 · under PA-12-282 | DUNCAN, DUSTIN THICKSON, DEMARC A | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $157,195 | ZRG1 |
| 2016 | Low-Threshold Incentivized HIV Care for Persons with Substance Use Disorders1R03DA042668-01 · under PA-15-290 | DOMBROWSKI, JULIA COOK | UNIVERSITY OF WASHINGTON, WA | $154,500 | ZRG1 |
| 2016 | Immune dysregulation in HIV-infected adults with substance abuse and the impact of addiction therapy1R03DA039731-01A1 · under PA-12-282 | LANCIONI, CHRISTINA LOUISE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $154,000 | ZRG1 |
| 2016 | SNS-based Data Mining to Understand MSM Substance use and HIV Risk Behavior1R03DA039752-01A1 · under PA-12-282 | HOLLOWAY, IAN WALTER | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $154,000 | ZRG1 |
| 2016 | The impact of marijuana use on brain and cognitive function in HIV-infected patients1R03DA041917-01A1 · under PA-15-290 | WILSON, TONY W | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $153,104 | ZRG1 |
| 2016 | Role of Social Media and Mobile Apps in Sexual and Drug Co-Usage Networks of MSM1R03DA039740-01A1 · under PA-12-282 | YOUNG, APRIL MARIE | UNIVERSITY OF KENTUCKY, KY | $152,612 | ZRG1 |
| 2015 | Neurocognitive development of goal-directed versus habitual learning1R03DA038701-01 · under PAR-12-066 | HARTLEY, CATHERINE ALEXANDRA | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $254,250 | ZDA1 |
| 2015 | The neural correlates of Pavlovian-to-instrumental transfer in real time1R03DA035305-01A1 · under PAR-12-066 | SCHILLER, DANIELA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZDA1 |
| 2015 | A New fMRI Method to Measure Substantia Nigra Signaling During Reward Processing1R03DA036655-01A1 · under PAR-12-066 | YOON, JONG H | PALO ALTO VETERANS INSTIT FOR RESEARCH, CA | $214,337 | ZDA1 |
| 2015 | Characterizing non-medical prescription opioid use and pain in people living with HIV1R03DA039743-01 · under PA-12-282 | KIPP, AARON M | VANDERBILT UNIVERSITY, TN | $157,000 | ZRG1 |
| 2015 | Cocaine mediated downregulation of SAMHD1 facilitates HIV-1 infection in CNS cells1R03DA037782-01A1 · under PA-12-282 | PILAKKA KANTHIKEEL, SUDHEESH | FLORIDA INTERNATIONAL UNIVERSITY, FL | $145,000 | ZRG1 |
| 2015 | HIV-1 Tat inhibition of RNAi: Implications for NeuroAIDS and Substance Abuse1R03DA039733-01 · under PA-12-282 | KLASE, ZACHARY ALAN | UNIVERSITY OF THE SCIENCES PHILADELPHIA, PA | $142,500 | ZRG1 |
| 2015 | Increasing rural substance-using African American women's access to evidenced-based HIV intervention1R03DA039744-01 · under PA-12-282 | HOOD, KRISTINA BEATRICE | MISSISSIPPI STATE UNIVERSITY, MS | $140,782 | ZRG1 |
| 2015 | Genome-wide DNA methylation in HIV infected drug users1R03DA039745-01 · under PA-12-282 | XU, KE | YALE UNIVERSITY, CT | $130,900 | ZRG1 |
| 2015 | Informing Dissemination of Behavior Therapies to Enhance HIV Care Among Substance Abusers1R03DA039719-01 · under PA-12-282 | HARTZLER, BRYAN J | UNIVERSITY OF WASHINGTON, WA | $125,045 | ZRG1 |
| 2015 | Development of Control Over Rewarding Stimuli: A Cognitive Neuroscience Approach1R03DA037405-01A1 · under PAR-12-066 | SHERIDAN, MARGARET ANN | BOSTON CHILDREN'S HOSPITAL, MA | $104,046 | ZDA1 |
| 2014 | Brain Mechanisms of Adolescent Bipolar Disorder as Risk Factor for Drug Abuse1R03DA036656-01A1 · under PAR-12-066 | PASSAROTTI, ALESSANDRA MARIA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $238,863 | ZDA1 |
| 2014 | Neural Substrates Associated with Executive Functioning in Marijuana and HIV1R03DA035670-01A1 · under PAR-12-066 | MEADE, CHRISTINA S | DUKE UNIVERSITY, NC | $235,500 | ZDA1 |
| 2014 | Imaging the Developing Fetal Brain: Novel Markers of Risk for Maternal Smoking1R03DA035896-01 · under PAR-12-066 | STROUD, LAURA R | MIRIAM HOSPITAL, RI | $228,368 | ZDA1 |
| 2014 | Prenatal cocaine exposure and functional connectivity in early infancy1R03DA036645-01A1 · under PAR-12-066 | GAO, WEIGREWEN, KAREN M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $228,000 | ZDA1 |
| 2014 | Exploring transitions to injecting among young adult non-medical opioid users1R03DA037770-01 · under PA-12-282 | MARSHALL, BRANDON DAVID LEWIS | BROWN UNIVERSITY, RI | $168,719 | ZRG1 |
| 2014 | Impact of Drug Use Treatment on HIV Risk Behaviors: An Integrative Data Analysis1R03DA037786-01 · under PA-12-282 | BROWN, JENNIFER L | TEXAS TECH UNIVERSITY, TX | $158,282 | ZRG1 |
| 2014 | Economic Debt, Drug Use, and HIV Risk among Sex Workers in Tijuana, Mexico1R03DA035699-01A1 · under PA-12-282 | REED, ELIZABETH ANN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $155,000 | ZRG1 |
| 2014 | Mir-125b/p53/POX axis and HIV-1 induced neurological damage1R03DA037779-01 · under PA-12-282 | PANDHARE, JUI | MEHARRY MEDICAL COLLEGE, TN | $145,500 | NAED |
| 2014 | The Family as Recovery Capital for HIV-Infected Male Injection Drug Users in Viet1R03DA037783-01 · under PA-12-282 | LE, GIANG M | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $134,316 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.